Related Experiment Video
Updated: Mar 4, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Gestational Diabetes Management Using Smart Mobile Telemedicine
Mercedes Rigla1, Iñaki Martínez-Sarriegui2, Gema García-Sáez2,3
11 Endocrinology and Nutrition Department, Parc Taulí University Hospital, Sabadell, Spain.
A new mobile telemedicine system improved gestational diabetes management. Patients using the system showed higher blood glucose monitoring compliance, indicating feasibility and acceptance.
Area of Science:
- Maternal-fetal medicine
- Digital health
- Artificial intelligence in healthcare
Background:
- Gestational diabetes (GDM) is a growing concern with long-term health risks for offspring.
- Effective GDM management is crucial but challenging due to limited healthcare resources.
- Telemedicine, augmented by AI, offers a potential solution for widespread GDM assistance.
Purpose of the Study:
- To evaluate the feasibility and acceptance of a mobile decision-support system for GDM management.
- To assess patient compliance with monitoring using the new system.
- To gauge user acceptance of the AI-powered telemedicine tool.
Main Methods:
- A pilot study involving 20 patients with GDM.
- Utilized a mobile decision-support system (MobiGuide Project) integrating clinical guidelines, EHR data, and sensor data (glucose, BP, activity).
- Compared blood glucose monitoring compliance with a historical cohort of 247 GDM patients.
Main Results:
- The mobile decision-support system demonstrated feasibility in managing GDM.
- Patients using the system exhibited higher compliance with blood glucose monitoring.
- A user questionnaire indicated a high degree of acceptance for the telemedicine system.
Conclusions:
- AI-augmented telemedicine systems are feasible for GDM management.
- This technology can improve patient compliance with essential monitoring protocols.
- The MobiGuide system shows promise for enhancing GDM care delivery.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Hypoglycemia and Glucagon

